Department of Internal Medicine, Korle Bu Teaching Hospital, Accra, Ghana.
World Health Organization Ghana Office, Accra, Ghana.
Pan Afr Med J. 2024 Jun 11;48:54. doi: 10.11604/pamj.2024.48.54.37911. eCollection 2024.
sub-Saharan Africa is experiencing a boom in the number of adolescents and young adults living with HIV (AYALHIV). Existing HIV intervention programs are mainly for children and adults living with HIV, with little attention paid to AYALHIV. Characterizing this population is necessary for planning, and designing, AYALHIV-centered HIV intervention programs.
a retrospective single-center, hospital-based chart review was conducted at the largest HIV clinic in Ghana. We examined routinely collected data for AYALHIV (aged 10-24 years) on antiretroviral therapy (ART) for at least 1 year and in active care from 1 January to 31 December 2019. Data was collected using a structured data extraction form. The Chi-square and the Student´s t-test were used to compare characteristics between adolescents and young adults.
of 252 AYALHIV, 68% (172/252) were adolescents with a median age of 17 years (IQR 13-19); 32% were young adults with a median age of 22 years (IQR: 20-24). Most (56.7% (143/252)) AYALHIV were female. Almost 40% were orphans. Eighty-six percent of AYALHIV had HIV type I infection. The commonest mode of HIV acquisition among adolescents was vertical transmission (70.5%) and that among young adults was via unprotected sex (31.3%). Eighty-eight percent (88%) of AYALHIV were on non-nucleoside reverse transcriptase inhibitors-based regimen. The viral suppression rate among AYALHIV was 78%.
the study shows there is a growing population of AYALHIV most of which are adolescents. About two-fifths were orphans. Policymakers and HIV programs should ensure AYALHIV-centred interventions are developed for this vulnerable population.
撒哈拉以南非洲的艾滋病毒感染者(HIV)青少年和青年人数正在增加。现有的艾滋病毒干预方案主要针对儿童和成人 HIV 感染者,很少关注青少年和青年 HIV 感染者。为了规划和设计以青少年和青年 HIV 感染者为中心的艾滋病毒干预方案,有必要对这一人群进行特征描述。
我们对加纳最大的艾滋病毒诊所进行了一项回顾性的单中心、基于医院的病历回顾研究。我们对至少接受了 1 年抗逆转录病毒治疗(ART)且在 2019 年 1 月 1 日至 12 月 31 日期间处于积极治疗中的青少年和青年 HIV 感染者(年龄为 10-24 岁)的常规收集数据进行了检查。数据是使用结构化数据提取表收集的。采用卡方检验和学生 t 检验比较青少年和青年之间的特征。
在 252 名青少年和青年 HIV 感染者中,68%(172/252)为青少年,中位数年龄为 17 岁(IQR 13-19);32%为青年,中位数年龄为 22 岁(IQR:20-24)。大多数(56.7%(143/252))青少年和青年 HIV 感染者为女性。将近 40%为孤儿。86%的青少年和青年 HIV 感染者感染了 HIV 型 I 。青少年中最常见的艾滋病毒感染途径是垂直传播(70.5%),青年中最常见的途径是无保护性行为(31.3%)。88%(88%)的青少年和青年 HIV 感染者接受基于非核苷类逆转录酶抑制剂的方案治疗。青少年和青年 HIV 感染者的病毒抑制率为 78%。
研究表明,青少年和青年 HIV 感染者人数不断增加,其中大多数为青少年。大约五分之二是孤儿。决策者和艾滋病毒规划者应确保为这一弱势群体制定以青少年和青年 HIV 感染者为中心的干预措施。